These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 21953737)

  • 21. Neuropsychological deficits in Parkinson's disease patients with visual hallucinations.
    Ramírez-Ruiz B; Junqué C; Martí MJ; Valldeoriola F; Tolosa E
    Mov Disord; 2006 Sep; 21(9):1483-7. PubMed ID: 16705661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual hallucinations and altered visual information processing in Parkinson disease and dementia with Lewy bodies.
    Kurita A; Murakami M; Takagi S; Matsushima M; Suzuki M
    Mov Disord; 2010 Jan; 25(2):167-71. PubMed ID: 20063433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis.
    Goetz CG; Emre M; Dubois B
    Ann Neurol; 2008 Dec; 64 Suppl 2():S81-92. PubMed ID: 19127578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics, correlates, and assessment of psychosis in Parkinson disease without dementia.
    Barrett MJ; Smolkin ME; Flanigan JL; Shah BB; Harrison MB; Sperling SA
    Parkinsonism Relat Disord; 2017 Oct; 43():56-60. PubMed ID: 28735797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study.
    Aarsland D; Larsen JP; Tandberg E; Laake K
    J Am Geriatr Soc; 2000 Aug; 48(8):938-42. PubMed ID: 10968298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poor visual discrimination and visual hallucinations in Parkinson's disease.
    Diederich NJ; Goetz CG; Raman R; Pappert EJ; Leurgans S; Piery V
    Clin Neuropharmacol; 1998; 21(5):289-95. PubMed ID: 9789709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonmotor Symptoms and Cognitive Decline in de novo Parkinson's Disease.
    Kwon KY; Kang SH; Kim M; Lee HM; Jang JW; Kim JY; Lee SM; Koh SB
    Can J Neurol Sci; 2014 Sep; 41(5):597-602. PubMed ID: 25373810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing.
    Abe Y; Kachi T; Kato T; Arahata Y; Yamada T; Washimi Y; Iwai K; Ito K; Yanagisawa N; Sobue G
    J Neurol Neurosurg Psychiatry; 2003 Apr; 74(4):419-22. PubMed ID: 12640053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of cognitive impairment in patients with Parkinson's disease: prevalence and risk factors.
    Wang Q; Zhang Z; Li L; Wen H; Xu Q
    Clin Interv Aging; 2014; 9():275-81. PubMed ID: 24550669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diplopia in Parkinson's disease: visual illusion or oculomotor impairment?
    Visser F; Vlaar AMM; Borm CDJM; Apostolov V; Lee YX; Notting IC; Weinstein HC; Berendse HW
    J Neurol; 2019 Oct; 266(10):2457-2464. PubMed ID: 31214767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R).
    Athey RJ; Porter RW; Walker RW
    Age Ageing; 2005 May; 34(3):268-73. PubMed ID: 15863411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cognitive and neuropsychiatric disorders in Parkinson's disease].
    Rodríguez-Constenla I; Cabo-López I; Bellas-Lamas P; Cebrián E
    Rev Neurol; 2010 Feb; 50 Suppl 2():S33-9. PubMed ID: 20205140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study of hallucinations and delusions in Parkinson's disease.
    Holroyd S; Currie L; Wooten GF
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):734-8. PubMed ID: 11385005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual dysfunction in patients with idiopathic rapid eye movement sleep behavior disorder.
    Li Y; Zhang H; Mao W; Liu X; Hao S; Zhou Y; Ma J; Gu Z; Chan P
    Neurosci Lett; 2019 Sep; 709():134360. PubMed ID: 31269466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical phenotype of Parkinson disease dementia.
    Galvin JE; Pollack J; Morris JC
    Neurology; 2006 Nov; 67(9):1605-11. PubMed ID: 17101891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with drug-induced visual hallucinations in Parkinson's disease.
    Papapetropoulos S; Argyriou AA; Ellul J
    J Neurol; 2005 Oct; 252(10):1223-8. PubMed ID: 15834642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Categorising Visual Hallucinations in Early Parkinson's Disease.
    Clegg BJ; Duncan GW; Khoo TK; Barker RA; Burn DJ; Yarnall AJ; Lawson RA
    J Parkinsons Dis; 2018; 8(3):447-453. PubMed ID: 30040741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease.
    Llebaria G; Pagonabarraga J; Martínez-Corral M; García-Sánchez C; Pascual-Sedano B; Gironell A; Kulisevsky J
    Mov Disord; 2010 Dec; 25(16):2785-91. PubMed ID: 20960483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining visual illusions in Parkinson's disease: Kinetopsia and object misidentification illusions.
    Nishio Y; Yokoi K; Hirayama K; Ishioka T; Hosokai Y; Gang M; Uchiyama M; Baba T; Suzuki K; Takeda A; Mori E
    Parkinsonism Relat Disord; 2018 Oct; 55():111-116. PubMed ID: 29891431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive correlates of hallucinations and delusions in Parkinson's disease.
    Factor SA; Scullin MK; Sollinger AB; Land JO; Wood-Siverio C; Zanders L; Freeman A; Bliwise DL; McDonald WM; Goldstein FC
    J Neurol Sci; 2014 Dec; 347(1-2):316-21. PubMed ID: 25466695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.